Assembly Calls for Givinostat Access for Duchenne Muscular Dystrophy Patients
A recent motion presented in the Assembly has received unanimous support, highlighting the availability of the Givinostat Early Access Programme for individuals diagnosed with Duchenne muscular dystrophy. The initiative is aimed at providing the medication at no cost to the NHS while it undergoes evaluation by health authorities in the UK.
Details of the Early Access Programme
The motion, moved by James Small-Edwards AM and seconded by Krupesh Hirani AM, underscored the need for the Givinostat treatment to be accessible to all eligible patients who stand to benefit from it. This programme was described as a compassionate use initiative implemented by the drug’s manufacturer, ensuring that those waiting for the comprehensive assessment can still receive the necessary medical support.
Community Support and Collaboration
The Assembly also commended the efforts of the charities Duchenne UK and Joining Jack for their role in disseminating information about the Early Access Programme. Their ongoing collaboration with NHS partners has been pivotal in facilitating access to the treatment for eligible patients.
Resource Allocation for NHS Trusts
In addition to advocating for patient access, the Assembly acknowledged that NHS Trusts in London may need extra resources and guidance to effectively engage with the Givinostat programme. To address this, they urged the Mayor to coordinate with NHS England, the Department of Health and Social Care, and local NHS Trusts to ensure that the necessary support structures are established for timely patient access.
Importance of the Initiative
This motion not only reinforces the importance of timely treatment for Duchenne muscular dystrophy but also emphasizes collaborative efforts between healthcare providers and charitable organisations. As Duchenne muscular dystrophy affects many families across the UK, ensuring access to innovative treatments such as Givinostat is critical for improving patient outcomes.
Source: official statements, news agencies, and public reports.
https://www.london.gov.uk/motions/givinostat-early-access-programme
